oncgnostics GmbH
The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on epigenetic biomarkers.
oncgnostics GmbH is working according to ISO 13485 standards in research, development, production and management.
Our Topics
Recent Posts
Contact
oncgnostics GmbH
BioInstrumentezentrum Jena
Winzerlaer Str. 2
07745 Jena
Germany
Phone: +49 (0)3641 5548500
Email: contact[at]oncgnostics.com
Internet: www.oncgnostics.com
On the World Mental Health Day
Press ReleasesAbnormal results in Cervical Cancer Screening may trigger symptoms of post-traumatic stress disorder. Oncgnostics GmbH draws attention to this on the annual World Mental Health Day on 10 October and points out that conspicuous Pap test results and/or positive HPV tests have a negative effect on the psyche of the women concerned. The company, which […]
Cancer screening: Suddenly, it has an effect on family planning
Press ReleasesExperience reports from women who are in family planning, but for whom a conspicuous finding was made during cancer screening, are often characterised by uncertainty and frustration. After a joint appeal with anti-cancer activist Myriam von M., many women told us their stories. Some of them experienced high-risk pregnancies or even miscarriages after a conisation. […]
Cervical cancer screening in Cuba
UncategorizedDuring the first days of March, Dr. Alfred Hansel took a close look at the healthcare system of Cuba. The Managing Director of oncgnostics GmbH participated in the Cuban-German Healthtech Summit in Havana. Cervical cancer and its early detection is a big issue in Cuba. Dr. Alfred Hansel, Managing Director of oncgnostics GmbH, attended the […]
Human papillomaviruses (HPV) – What is it?
UncategorizedHuman papillomaviruses are a group of widespread viruses. In most cases, people affected by the virus are unaware of the infection. However, certain types of HPV are responsible for the development of tumours, such as cervical cancer. Almost everyone gets infected with HPV at some point in their lives. HP viruses are mainly transmitted by […]
Sepsis: In which Patients does the Immune System Break Down?
Press ReleasesAs part of a new EU consortium, Oncgnostics GmbH is investigating diagnostic possibilities of immune collapse after sepsis. More than 140 people die every day in Germany of sepsis, commonly known as blood poisoning. Two thirds of them do not die from the out of control inflammatory reactions in the whole body, but rather from […]
MEDICA and COMPAMED 2019
UncategorizedFrom 18 to 21 November we attended MEDICA 2019, in Düsseldorf. We were at the joint booth for the industry association medways e.V. in the world’s largest trade fair for the medical sector. Record Number of Exhibitors and Visitors This year the trade fair broke its own record once again with around 5,500 exhibitors and […]
Oncgnostics Expands Business Relations in Asia
Press ReleasesApproval for cervical cancer screening test in the Chinese market expected in early 2020 / First contacts in Japan Shanghai/Yokohama/Tokyo/Jena, 1 November 2019 –Our business partner in China, GeneoDx, is about to get approval to commercialise GynTect in the Chinese market. This issue was discussed at a business meeting with representatives from oncgnostics GmbH in […]
EURONEXT Chooses Oncgnostics
UncategorizedOncgnostics GmbH is greatly honoured to have been selected by EURONEXT for the TechShare programme. We will be participating in top-class workshops and coaching sessions for half a year. High-quality Coaching for Start-ups As one of eleven German start-ups in the medical and biotech sectors, we will have the opportunity to broaden our horizons over […]
Expert Lecture in Spain
UncategorizedOn 12 June, the conference ‘XIII Jornada de Formación en Patología del Tracto Genital inferior y Colposcopia‘ was held in Madrid. Oncgnostics’ managing director Dr Alfred Hansel was one of the speakers at the training event for gynaecologists. Experts Exchange Knowledge At the conference, experts updated their knowledge on HPV-related cancers in women’s genital tract. […]
Surprise at Investor Days Thüringen
UncategorizedOn 18 June oncgnostics managing director, Dr Alfred Hansel, visited Investor Days Thüringen in Erfurt, and was pleased to receive the ‘bm|t sustainable business award’. Thuringia’s Sector Network Meeting As a large sector network meeting, Investor Days bring together the different parties involved: Young companies, investors, decision makers and representatives from economy, science and politics. […]